Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Novel Neuronal Calcium Channel Blockers
Marangos, Paul J.
Questcor Pharmaceuticals, Hayward, CA, United States
Search 6 grants from Paul Marangos
Search grants from Questcor Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Foundational tools to study the impacts of sympathetic activity on the neuroanatomy and function of brown adipose tissue
Role and regulation of class IIa HDACs in cocaine addiction
Immunologic and pharmacologic studies in allotransplant
Targeting CNTF to increase adult forebrain neurogenesis
Substance Abuse Prevention and Treatment: Working with the Criminal Justice Syste
Recently added grants:
Radiation-induced astrocyte dysfunction and cognitive decline
Preclinical development of breakthrough immunotherapy for brain tumors
Homeostatic Stabilization of Neural Function in Health and Disease
Functional analysis of the microRNA-induced silencing complex in epilepsy
ER stress and neonatal hypoxia ischemia encephalopathy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS029908-03
Application #
2268008
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (08))
Project Start
1991-09-15
Project End
1996-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Questcor Pharmaceuticals
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Related projects
NIH 1995
R44 NS
Development of Novel Neuronal Calcium Channel Blockers
Marangos, Paul J. / Questcor Pharmaceuticals
NIH 1994
R44 NS
Development of Novel Neuronal Calcium Channel Blockers
Marangos, Paul J. / Questcor Pharmaceuticals
Comments
Be the first to comment on Paul Marangos's grant